Park Dental Partners, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SWENSON PETER G, was filed 05 Dec 2025.
Park Dental Partners, Inc.: what insiders have been doing
Park Dental Partners, Inc., classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 8 November 2026, brought 9 filings signed by 6 insiders.
The flow runs one way only: 6 insiders bought (7 purchases totalling €302k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €86k, bought by Smith Christopher Charles and made public on 3 December 2025. The buyers include 4 senior executives, 1 finance chief and 1 chief executive.
Across the 5,810 companies tracked on its exchange, the median is 19 filings; at 9 filings, this issuer sits below that mark. Our records for Park Dental Partners, Inc. go back to 2025, with 7 purchases and no sales on the open market in total.
In the case of 7 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (5 December 2025) now reads 338 days.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +44.4%Entry US$13.22 · Close 15 Oct 2026 US$19.09
- +65.4%Entry US$11.54 · Close 15 Oct 2026 US$19.09
- +65.4%Entry US$11.54 · Close 15 Oct 2026 US$19.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 40 sharesCommon StockSEC:0002088869-26-000001:0
- 40 sharesCommon StockSEC:0002088869-26-000001:1
- 3,169 shares@ US$13.000.043% mcap45.2% of flowCommon StockSEC:0002088869-25-000023:0Canonical exit: 3 Mar 2026 (T+90)
- 7,692 shares@ US$13.00100.0% of flowCommon StockSEC:0002088869-25-000022:0Canonical exit: 3 Mar 2026 (T+90)
- 769 shares@ US$13.00100.0% of flowCommon StockSEC:0002088869-25-000021:0Canonical exit: 3 Mar 2026 (T+90)
- 1,923 shares@ US$13.00100.0% of flowCommon StockSEC:0002088869-25-000020:0Canonical exit: 3 Mar 2026 (T+90)
- 7,692 shares@ US$13.00100.0% of flowCommon StockSEC:0002088869-25-000019:0Canonical exit: 3 Mar 2026 (T+90)
- 1,923 shares@ US$13.00100.0% of flowCommon StockSEC:0002088869-25-000018:0Canonical exit: 3 Mar 2026 (T+90)
- 3,846 shares@ US$13.0054.8% of flowCommon StockSEC:0002088869-25-000017:0Canonical exit: 3 Mar 2026 (T+90)
9 of 9 declarations
About Park Dental Partners, Inc.
Park Dental Partners, Inc. (NASDAQ: PARK) is a United States-based dental services platform structured as a dental resource organization (DRO). Headquartered in Roseville, Minnesota, the company provides comprehensive non-clinical support to affiliated general and multi-specialty dental practices. Its service model includes clinical team members, administrative personnel, facilities, equipment, technology, and centralized operational support. For investors, the business is best understood as a dental network enabler rather than a traditional single-site provider: Park Dental Partners helps affiliated practices run efficiently while clinicians focus on patient care.
The company traces its operating heritage back to 1972, when its general dentistry group was established. Park Dental Partners also highlights a long-standing commitment to quality and clinical standards, including an accreditation milestone achieved in 1979 by what is now the Accreditation Association for Ambulatory Health Care. The current corporate structure was formalized in 2023, building on decades of collaboration between Park Dental and The Dental Specialists. That history matters strategically, because it suggests that Park Dental Partners entered public markets with an established operating base rather than as a newly created roll-up.
Read moreShow less
Its core business is the support of affiliated dental practices across a broad set of services. The company’s network offers general dentistry as well as specialty care such as oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. This multi-specialty footprint is important competitively: it supports patient retention, broadens the service mix, and allows the company to leverage shared infrastructure across practices. The model also creates operating leverage when new clinics or specialists are added to the network.
Geographically, the business is primarily concentrated in Minnesota and Wisconsin, with expansion beyond its historical core now visible in Arizona. Recent company communications indicate a network supporting more than 200 dentists across roughly 85 to 88 practice locations in three states, along with a large clinical support workforce. That regional concentration gives the company meaningful density in core markets, while also exposing it to local reimbursement, labor, and competitive dynamics.
Recent developments are notable. Park Dental Partners began trading on The Nasdaq Capital Market on December 3, 2025, following its initial public offering. In early 2026, management reported full-year 2025 results, including revenue growth, new acquisitions in Minnesota and Arizona, and the opening of a de novo multi-specialty practice in Rochester, Minnesota. The company also highlighted additional affiliations and rebranding activity across its platform. For investors, the near-term story is centered on disciplined expansion, integration of new practices, and execution in a service-intensive healthcare niche. Within the Health & Pharma sector in the United States, PARK is a relatively recent listed name, but one with a long operating history and a clearly defined consolidation strategy.
